Beneficient (BENF) Stock Analysis

Price updated 4 days ago · SEC data refreshed 3 months ago · Not investment advice

Beneficient

BENF Financial Services Financial Services📄 SEC filings ↗
Valuation N/A
▾ What's in the 42/100 risk score? (higher = riskier)
Fundamental health (43%) 20/100 → +8.6
leverage 20/100
Smart money (short interest + insider buying) (31%) 79/100 → +24.8
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (26%) 33/100 → +8.5
Total42/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). See the Financial Health section for the full balance-sheet read.

💵 Price $1.06 · 4 days ago 📄 Financials SEC EDGAR · refreshed 3 months ago

How to read BENF (pre-profit growth)

This company is reinvesting instead of generating profit, so a standard DCF cannot price it. The useful question is whether the growth the market is paying for is achievable — and whether the company can fund itself until then.

Where to start — the sections that matter most for this stock
  1. 1 Reverse-DCF — the growth the price demands ↓
    It shows exactly how fast the business must grow to justify today's price. Compare that to what comparable companies have actually achieved.
  2. 2 Cash runway ↓
    Can it reach profitability before it has to raise money and dilute shareholders?
  3. 3 Interactive calculator ↓
    Set your own growth + margin assumptions and see what the business would be worth if you are right.
Or — what are you trying to decide?
A note on process: fear-driven decisions — including fear of missing out — tend to be the expensive ones. A stock up 10% a day for three days is excitement, not evidence. Whichever reader you are, the data below is there to be checked before anything is decided.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.
ⓘ A share-count quirk blocked the per-share math

The share count we read for BENF looks wrong — common for multi-class / founder-controlled filers that report shares per share-class. That makes per-share figures (including intrinsic value) misleading, so we suppressed them. The company's total financials below are sound.

What to use instead: Lean on the totals — revenue, net income, cash flow — and the balance sheet. Multi-class share counts are being corrected; once fixed, the per-share valuation returns automatically.

This note is only about the single DCF fair-value number — BENF's full financial statements, health scores, and written analysis are all below.

Loading insider & short-seller data…
Checking filings for failure warnings…

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
Not available for this filer

The Z-score needs working capital, retained earnings, EBIT, sales and total assets from the latest balance sheet, and at least one of those isn't reported in machine-readable form here — common for foreign private issuers. We leave it blank rather than compute a distress verdict from an estimated input. It doesn't affect the reported figures in the financial tables below.

Piotroski-style checks (partial — not a standard F-score)
2 passed · 3 failed · 4 n/a
Partial result, not a standard F-score: 2 of 5 measurable checks passed. 4 of the 9 standard checks couldn't be measured, so this is scored out of 5, not 9 — it isn't comparable to a published F-score.
▾ The checks — what passed, what didn't (and what we couldn't measure)
  • Positive net income
    Net income -$0.8M in FY2025.
    Why this matters: Does the company actually earn a profit? Sustained losses eventually force it to raise money — diluting you — or take on debt.
  • Positive operating cash flow
    Operating cash flow -$37.7M (was -$58.2M the prior year).
    Why this matters: Profit can be an accounting figure; cash from running the business is harder to fake. Negative operating cash flow means the core business consumes cash and must be funded externally.
  • Cash flow backs up reported profit
    Operating cash flow -$37.7M vs net income -$0.8M.
    Why this matters: When cash generated exceeds reported earnings, profits are high-quality (not propped up by accruals or one-time items).
  • Return on assets improving
    Return on assets -0.2% vs -721.3% a year ago.
  • Debt load (vs assets)
    The filing reports no interest-bearing debt in either year (total assets $354.9M).
  • · Short-term liquidity (current ratio) (n/a — data not reported; not scored)
  • · Share count (dilution) (n/a — data not reported; not scored)
  • · Pricing power (gross margin) (n/a — data not reported; not scored)
  • · Sales per asset (asset turnover) (n/a — data not reported; not scored)

Missing data is never counted as a pass or a fail — it's shown as n/a and excluded from the denominator. Each check compares the company against its own prior year.

Cash Runway
0 mo
CRITICAL — under 6 months of cash

Plain English: the company holds about $1M in cash and is burning roughly $38M/year in operations. At that pace, the cash lasts 0 mo before it must raise capital (diluting shareholders), take on debt, or cut spending.

Assumes constant burn and ignores financing/asset sales. For pre-profit biotech and growth companies, this matters more than a DCF — a great drug pipeline is worthless if they run out of money before approval.

Price$1.06
Model IVNot applicable — DCF couldn't price this stock. The other valuation lenses on this page (reverse-DCF, peers, sector lens — whichever apply to this filer) carry the read instead.

A standard discounted cash flow?DCF — Discounted Cash Flow — sums up all future cash a business will produce, adjusted for the fact that future dollars are worth less than dollars today.
Why it matters: It is the most fundamentally honest valuation method when applicable — but only works for companies with predictable, positive cash flow.
Reference: Best for: mature, profitable businesses. Fails for: pre-profit growth, banks, REITs.
Full explanation →
(DCF) valuation is not meaningful for Beneficient because it has consistently negative operating cash flow and net income, indicating a cash-burning growth stage. Investors are likely betting on the company's future ability to generate positive cash flows from its unique financial services offerings. The market may be assigning value to the potential for regulatory changes that could expand its addressable market, which is not in the model. The number one quantifiable risk is the continued negative operating cash flow, which implies ongoing reliance on external funding.

⚠️ FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.

As of 3 months ago

Anatomy of a share

What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

Per-share economics aren't reliable for this filer. Its income statement or share count isn't fully reported to SEC EDGAR (common for foreign private issuers and thinly-disclosed OTC names), so we don't break it down per share here — the figures would be misleading. See the financial tables below for what is reported.

What you actually need to decide

Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

🐂 The Bull Case
Operating cash flow must turn positive and grow consistently to demonstrate the viability of its business model and reduce reliance on external funding.
🐻 The Bear Case
Continued negative operating cash flow, as seen in the latest period and 0/5 years, implies ongoing cash burn and potential dilution from future equity raises.
📌 Signposts to watch — update your view as these print
  • Growth in assets under administration (AUA)
  • Improvement in net income towards profitability
  • Positive operating cash flow generation

The trend, in plain numbers (FY2024 → FY2025, latest reported)

Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.

✅ Improving
  • Free cash flow is negative at -$44.5M — the cash burn narrowed vs last year.
  • Still unprofitable at -$803K — loss narrowing.

Nothing was clearly worsening year-over-year.

Management & Leadership

Beneficient is led by its founder and Executive Chairman, Brad K. Heppner, who has been instrumental in shaping the company's vision and strategy since its inception. The current CEO is Thomas O. Hicks, Jr., who joined the company in 2021, bringing extensive experience in financial services and asset management.

Brad K. Heppner
Executive Chairman and Founder
Thomas O. Hicks, Jr.
Chief Executive Officer

What They Make

Beneficient provides liquidity solutions and trust services to owners of alternative assets, primarily serving high-net-worth individuals and small to mid-sized institutions. It offers a way for these clients to access capital from illiquid investments.

End Markets

High-net-worth individualsSmall institutionsMid-sized institutions

Revenue Drivers

Liquidity solutions for alternative assets
Trust services
Asset management fees
Beta: 0.55

Why Is It Priced Like This?

Why Customers Pay

Provides liquidity for illiquid alternative assets
Offers specialized trust and fiduciary services
Enables diversification for alternative asset holders
No discounted-cash-flow value for this filer This company's reported free cash flow is negative, so a discounted-cash-flow valuation has no positive cash stream to discount. That is a fact about the business, not missing data — the reported figures below are complete.

What we use instead: earnings (P/E, EV/EBIT), book value (P/B) — computed from the figures this company does report, shown in the sections below. Those numbers are unaffected by the missing cash-flow data.

The market is likely pricing Beneficient based on expectations of future revenue growth and the potential for its unique financial services model to achieve scale, rather than current cash flow, given its negative operating cash flow and net income. The market may be assigning value to the potential for network effects as more alternative asset holders utilize its platform, which is not in the model. Investors are focusing on the company's ability to expand its client base and product offerings to eventually turn profitable.

Business Model & Valuation

How They Make Money

Providing liquidity against alternative assets
Charging fees for trust and fiduciary services
Earning asset management fees on managed capital

The company funds itself primarily through equity raises and other external financing, as evidenced by its negative operating cash flow.

Growth / Revenue DCF

Negative free cash flow: revenue/margin growth model used - standard FCF DCF is unreliable for companies still scaling.

Show advanced inputs
Revenue Growth15.0%

What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project net interest income and fee-income lines independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

Maturity & Competitive Position

Growth / re-investment phase

Moat Signals

Specialized expertise in alternative asset liquidity
Proprietary technology for asset valuation
Regulatory licenses for trust services

Net income and operating cash flow have been negative in the latest period and for 0/5 years, indicating a challenging financial trend.

Geography & Markets

Beneficient is primarily focused on the US market, serving clients across various states. Specific geographic revenue splits are not available from current data sources.

Geographic Risks

Concentration risk in the US alternative asset market
Regulatory changes impacting alternative asset liquidity

Market Signals

These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

Model neutral, tape neutral - aligned.
RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
Reference: 30–70 normal · >70 overbought · <30 oversold
Full explanation →
(14)
57.3NeutralMomentum is balanced — neither overbought nor oversold.
MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
Reference: Line above signal = bullish momentum · below = bearish
Full explanation →
BullishLine above signalThe fast trend is above the slow trend — short-term momentum is currently upward.
50-Day Average$3.46Price below (-69.4%)Price below its 50-day average = near-term downtrend.
200-Day Average$4.32Price belowThe 200-day line is the long-term trend divider — above it is generally considered a bull market for the stock.
50 vs 200 CrossDeath50-day below 200-dayA "death cross" — the medium trend is below the long trend (often read as bearish).

Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

Data Quality & Risk Flags (9 notes — click to expand/collapse)

Guardrail Notes (9)
  • FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.
  • INVARIANT: scenario ordering inverted (conservative > optimistic). Results may be unreliable.
  • INVARIANT: weighted IV is non-positive. Model may not be appropriate.
  • Model implies no positive equity value under these assumptions. Valuation is speculative/low-confidence.
  • Shares from unknown — per-share values may be less accurate.
  • Illiquidity discount 25% applied (small/micro-cap — harder to exit, demand a margin).
  • Shares/market cap missing or defaulted; per-share valuation unreliable.
  • Shares defaulted to 1; IV is NOT meaningful — treat as data-unavailable.
  • DATA UNAVAILABLE: per-share values suppressed due to missing/unreliable shares data.

Financial Statements (5-year tables — click to expand)

From Beneficient's SEC filings (EDGAR).

Income (5yr)

YearRevenueNet IncomeEPS
2025-7.9M-803,000$0.00
2024-98.7M-2.7B
2023-104.9M-131.0M$-1.94
202155.3M-63.0M$-1.84
2020140.3M-58.0M$-1.27

Cash Flow (5yr)

YearOperating CFCapEx− SBC & adj.Free Cash Flow
2025 -37.7M 1.1M 5.6M -44.5M
2024 -58.2M 1.8M 39.1M -99.1M
2023 -95.1M 2.1M 10.1M -107.3M
2021 -57.0M 4.2M 23.2M -84.4M
2020 -54.0M 3.2M 107.8M -165.0M

How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). Latest year: -37.7M − 1.1M − 5.6M (SBC & adj.) = -44.5M. This is the same owner-earnings FCF definition the valuation model uses, though the DCF's starting value is a projected from revenue × terminal margin, not this single year.

Balance Sheet

Total Assets354.9M
Total Liabilities299.3M
Equity-34.9M

Similar companies worth a look

Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.

PG
Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
🔔 Follow $BENF — free insider alerts
One email when an insider buys $BENF on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.